Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody

相似書籍

• Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
  由: Lannfelt, Lars, et al.
  出版: (2014)
• Design of a Bayesian adaptive phase 2 proof-of-concept trial for BAN2401, a putative disease-modifying monoclonal antibody for the treatment of Alzheimer's disease
  由: Satlin, Andrew, et al.
  出版: (2016)
• A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
  由: Swanson, Chad J., et al.
  出版: (2021)
• Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
  由: Chad J. Swanson, et al.
  出版: (2022-05-01)
• Sensitive detection of Aβ protofibrils by proximity ligation - relevance for Alzheimer's disease
  由: Kamali-Moghaddam, Masood, et al.
  出版: (2010)